Recludix Pharma

Recludix Pharma is a biotechnology company specializing in the development of potent and selective inhibitors for challenging protein targets, particularly those involved in inflammatory diseases and cancer. They leverage a proprietary drug discovery platform integrating DNA-encoded libraries, structure-activity relationship determination, and a unique screening tool to ensure selectivity. Their primary focus is on SH2 domain inhibitors, with the most advanced programs centered on STAT (Signal Transducer and Activator of Transcription) proteins.

Recludix Pharma has a strategic partnership with Sanofi for the development and commercialization of a STAT6 inhibitor for immunological and inflammatory diseases. Additionally, they are advancing STAT3 inhibitors for Th17-mediated inflammatory diseases and oncology. The company is headquartered in San Diego, California, and has a second location in Cambridge, Massachusetts. They are recognized for their innovative approach to targeting previously undruggable targets and have attracted industry veterans and established partnerships to drive their mission forward.

Recludix Pharma offers flexibility in work location for the Sr./Director, DMPK position, with options to work in either San Diego, CA or Cambridge, MA.

Recludix Pharma offers a comprehensive benefits package to its employees and their families, including medical, dental, vision, life insurance, disability insurance, and a 401(k) plan with a company match. They also offer competitive salaries and bonus incentives benchmarked against the industry, as well as opportunities for professional development and growth. In addition to these benefits, Recludix Pharma provides wellness programs and an on-site gym for the physical well-being of its employees.

Recludix Pharma is a biotechnology company dedicated to developing innovative medicines for patients with inflammatory diseases and cancer. Their mission is to unlock new therapeutic possibilities by targeting previously undruggable protein targets, like SH2 domains, which are critical for regulating cell signaling pathways involved in these diseases. By combining custom DNA-encoded libraries, structure-activity relationship determination, and proprietary screening tools, Recludix aims to create transformative therapies while fostering a collaborative and inclusive workplace environment where employees can thrive.

Recludix Pharma cultivates a culture defined by deliberate action, collaboration, and enthusiasm. The company emphasizes scientific rigor, transparency, and continuous learning within a supportive and inclusive team environment. They value diversity and foster a sense of community where employees are encouraged to share ideas, contribute to a collective mission, and experience professional growth.

Recludix Pharma values diversity and believes that a diverse workforce leads to greater innovation. They prioritize an equitable and inclusive workplace, regardless of race, gender, ethnicity, religion, sexual orientation, national origin or other characteristics. This commitment is reflected in their Board of Directors, which has 50% female representation, including the Chairperson. They also offer competitive salaries and benefits, opportunities for professional development, and wellness programs to ensure their employees thrive.